BELFAST, Northern Ireland, Feb. 24, 2025 /PRNewswire/ — Neurovalens, a global leader in noninvasive neurostimulation technology, is making significant strides in addressing chronic insomnia among U.S. veterans. The company’s FDA-cleared, drug-free insomnia treatment device, Modius Sleep, is now available to veterans through the U.S. Department of Veterans Affairs (VA) program.
Neurovalens Expands Access to Modius Sleep for Veterans Through U.S. Department of Veterans Affairs (VA) Program
